[Federal Register Volume 67, Number 228 (Tuesday, November 26, 2002)]
[Notices]
[Page 70752]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-29928]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Blood Products Advisory Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Blood Products Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on December 12, 2002, from 
8 a.m. to 6 p.m.
    Location: Holiday Inn, Ballroom, Two Montgomery Village Ave., 
Gaithersburg, MD.
    Contact: Linda A. Smallwood, Center for Biologics Evaluation and 
Research (HFM-302), Food and Drug Administration, 1401 Rockville Pike, 
Rockville, MD 20852, 301-827-3514, or FDA Advisory Committee 
Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC 
area), code 19516. Please call the Information Line for up-to-date 
information on this meeting.
    Agenda: On December 12, 2002, the following committee updates are 
tentatively scheduled: (1) Summary of West Nile Virus workshop, 
November 4 and 5, 2002; (2) Medical Device User Fee and Modernization 
Act of 2002 (Public Law 107-250), and (3) human immunodeficiency virus 
(HIV) rapid tests. In the morning, the committee will hear 
presentations, and discuss and provide recommendations on the topic of 
bacterial contamination. In the afternoon, the committee will hear 
presentations on human parvovirus B19 nucleic acid testing for whole 
blood and source plasma, and discuss and provide recommendations.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by November 22, 
2002. Oral presentations from the public will be scheduled between 
approximately 11:15 a.m. and 12:15 p.m. and 4:30 p.m. and 5 p.m. Time 
allotted for each presentation may be limited. Those desiring to make 
formal oral presentations should notify the contact person before 
November 22, 2002, and submit a brief statement of the general nature 
of the evidence or arguments they wish to present, the names and 
addresses of proposed participants, and an indication of the 
approximate time requested to make their presentation.
    Persons attending FDA's advisory committee meetings are advised 
that the agency is not responsible for providing access to electrical 
outlets.
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact Linda A. Smallwood 
or Pearline K. Muckelvene at 301-827-1281 at least 7 days in advance of 
the meeting.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: November 20, 2002.
Linda Arey Skladany,
Associate Commissioner for External Relations.
[FR Doc. 02-29928 Filed 11-25-02; 8:45 am]
BILLING CODE 4160-01-S